Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.
USD 29.95
Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.

Contact Information

Legal Address
No 75, Braybrooke Place,Hemas House
Colombo; Western Province; Map
Tel: +94-011473,+94-011290
Fax: +94-011473
Email: @jlmorisons.com

Full name: J. L. Morison Sons & Jones (Ceylon) Plc

Status: Listed
Legal Form: Public Limited Company
Operational Status: Operational
EMISid: 2313947
ISIN: LK0091N00005
Incorporation Date: 1939

Main Activities

Main Activities: Pharmaceutical and Medicine Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers | Chemical and Allied Products Merchant Wholesalers

Main Products

pharmaceuticals

Company Description

J. L. Morison Son & Jones (Ceylon) PLC engages in produces and imports finished pharmaceuticals, toiletries, agro chemicals, medical aid, and other consumer products in Sri Lanka. It also offers milk foods, biscuits, household insecticides, shoe care, hair care products, and diagnostics reagent and equipments. In addition, the company, through its subsidiaries, engages in manufacturing and trading toiletry, and cosmetic products; and the promotional and wharf clearing activities, as well as provides goods…

More

Basic Information

Outstanding Shares:
: ()
Financial Auditors:
()

EMIS Benchmark Score

View all parameters in Benchmark Score

Quote Chart

Quote Summary

Last Price 351.20
Volume 2
Turnover 652
Index
Market EXCH
Ticker MORI.N0000
Market Cap Market Cap 2,560,960
52 Week High 380.60
52 Week Low 300.00
Price to Earnings (P/E)
Earnings per Share (EPS)
Dividend Yield
Bookvalue
Enterprise Value
Quote updated on November 23, 2016
Note: data in LKR Thousands.

Key Executives

Chairman

Ownership Details

Hemas Manufacturing (Private)Limited
92.26%
More

Key Stats

Select Items to chart them. 2016 Q3C
Net sales revenue
Total operating revenue
Operating profit (EBIT)
EBITDA
Net Profit (Loss)
Total assets 3,970,853
Total equity
Operating Profit (EBIT) Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to Equity
Quick Ratio
Cash Ratio
Note: units in Thousands. Statement: Non-Audited, Consolidated
Source: World's Vest Base, EMIS Company Database.

Financials

Competitors - Sri Lanka

LKR | USD | EUR

EMIS DealWatch Deals

DealMonitor Deal Intents

for 29.95 USD
Payment methods include:
USD 29.95
Most recent financial data: 2015
Payment methods include:
The full PDF report for this company will be available to download immediately after purchase. The report will contain:
Company Tear Sheet
Contact Information
NAICS Industry Classification
Business description
Basic Information
Share Price information
Key Executives
Ownership Details
Subsidiaries and Affiliates
Key Financial Highlights
Financial Performance Charts
Latest M&A and ECM Deals
Top Competitors
Financial Statements
Annual Statements
Ratios
EMIS Credit Analytics
EMIS Benchmark Score

- or -

EMIS company profiles are part of a larger information service that combines company, industry and country data and analysis for over 120 emerging markets on a unique information platform.

If you need broad and deep coverage of one or many countries, you may be interested in subscribing. Request a demonstration of our full service and one of our account managers will be in touch.

Register Your Interest